Vistagen appoints Angel Angelov as Chief Medical Officer with $425K salary and 150K options

Filed May 19, 2026 · Period ending May 18, 2026 · ~1 min read

Key Changes

• medium

  Dr. Angel Angelov, 57, joins as CMO effective May 18, 2026. He previously served as CMO at Theranica and held senior medical roles at Karuna Therapeutics and Neurocrine Biosciences, bringing deep experience in neurological and psychiatric drug development.

  Item 5.02 verify on EDGAR →
• low

  Compensation package includes $425,000 annual base salary, $50,000 signing bonus (paid in two installments), and eligibility for 45% annual bonus based on performance goals set by the Board.

  Item 5.02 verify on EDGAR →
• low

  Dr. Angelov received stock options for 150,000 shares at $0.5955 exercise price, vesting over four years (cliff after year one, then monthly over three years). Options expire in ten years.

  Item 5.02 verify on EDGAR →